
  
    
      
        Background_NNP
        The_DT aldehyde_NN dehydrogenase_NN (_( ALDH_NNP )_) superfamily_RB of_IN enzymes_NNS
        consists_VBZ of_IN a_DT group_NN of_IN NAD_NNP (_( P_NN )_) -_: dependent_JJ enzymes_NNS which_WDT can_MD
        oxidize_NN a_DT structurally_RB diverse_JJ group_NN of_IN endogenous_JJ and_CC
        exogenous_JJ aldehyde_NN substrates_NNS ._. Seventeen_CD 
        ALDH_NNP genes_NNS have_VBP been_VBN identified_VBN in_IN
        the_DT human_JJ genome_NN and_CC have_VBP been_VBN classified_VBN into_IN ten_CD
        different_JJ families_NNS based_VBN on_IN amino_JJ acid_NN sequence_NN identities_NNS
        [_NN 1_CD 2_CD ]_NN ._. High_NNP levels_NNS of_IN ALDH_NNP 1_CD A_DT 1_CD activity_NN can_MD protect_VB human_NN
        and_CC murine_NN cells_NNS from_IN the_DT toxicity_NN of_IN the_DT alkylating_VBG agent_NN
        cyclophosphamide_NN and_CC its_PRP$ oxazaphosphorine_NN analogs_NNS ._. Indeed_RB
        it_PRP was_VBD hypothesized_VBN that_IN the_DT high_JJ expression_NN of_IN ALDH_NNP 1_CD A_DT 1_CD
        (_( formerly_RB known_VBN as_IN class_NN 1_CD ALDH_NNP )_) was_VBD responsible_JJ for_IN the_DT
        successful_JJ use_NN of_IN cyclophosphamide_NN in_IN tumor_NN cell_NN purging_VBG
        regimens_NNS during_IN bone_NN marrow_NN transplantation_NN [_NN 3_CD ]_NN ._. The_DT
        detection_NN of_IN elevated_VBD ALDH_NNP 1_CD A_DT 1_CD activity_NN in_IN the_DT most_RBS
        primitive_JJ human_JJ hematopoietic_JJ progenitor_NN cells_NNS [_NN 4_CD 5_CD 6_CD ]_NN
        has_VBZ provided_VBN evidence_NN in_IN support_NN of_IN this_DT hypothesis_NNS ._.
        However_RB ,_, no_DT physiologic_JJ role_NN for_IN this_DT enzyme_NN in_IN the_DT
        hematopoietic_JJ stem_NN cell_NN population_NN has_VBZ been_VBN identified_VBN ._.
        Vitamin_NNP A_DT (_( retinol_NN )_) is_VBZ the_DT prototype_NN of_IN a_DT class_NN of_IN
        natural_JJ and_CC synthetic_JJ chemical_NN compounds_NNS named_VBD the_DT
        retinoids_NNS ._. Retinoids_NNP are_VBP found_VBN in_IN a_DT variety_NN of_IN chemical_NN
        oxidation_NN states_NNS ,_, including_VBG alcohol_NN ,_, aldehyde_NN ,_, ester_NN ,_, and_CC
        carboxylic_JJ acid_NN functionalities_NNS ._. The_DT acid_NN form_NN ,_, retinoic_JJ
        acid_NN ,_, is_VBZ a_DT pleiotropic_JJ hormone_NN which_WDT regulates_VBZ gene_NN
        expression_NN in_IN embryonic_JJ development_NN ,_, epithelial_NN cell_NN
        differentiation_NN ,_, hematopoeisis_NNS ,_, and_CC tumor_NN cell_NN
        formation_NN ._.
        Several_JJ enzymes_NNS ,_, including_VBG isoforms_NNS of_IN alcohol_NN
        dehydrogenase_NN ,_, ALDH_NNP ,_, and_CC cytochrome_NN P_NN 450_CD (_( CYP_NNP )_) ,_, recently_RB
        have_VBP been_VBN shown_VBN to_TO be_VB involved_VBN in_IN the_DT formation_NN of_IN retinoic_JJ
        acid_NN from_IN retinol_NN and_CC retinal_JJ [_NN 7_CD 8_CD ]_NN ._. The_DT purification_NN ,_,
        cloning_VBG ,_, and_CC characterization_NN of_IN several_JJ ALDH_NNP enzymes_NNS which_WDT
        efficiently_RB catalyze_NN the_DT oxidation_NN of_IN retinal_JJ (_( Figure_NN 1_CD A_DT )_)
        has_VBZ suggested_VBN that_DT regulation_NN of_IN retinoic_JJ acid_NN formation_NN
        could_MD be_VB a_DT key_JJ physiologic_JJ role_NN for_IN these_DT enzymes_NNS ._. The_DT
        report_NN of_IN the_DT crystal_NN structure_NN of_IN the_DT homotetrameric_JJ
        ALDH_NNP 1_CD A_DT 1_CD enzyme_NN from_IN sheep_NN liver_NN revealed_VBD a_DT substrate_NN tunnel_NN
        capable_JJ of_IN binding_JJ retinal_JJ which_WDT was_VBD absent_JJ in_IN ALDH_NNP 2_CD and_CC
        ALDH_NNP 3_CD A_DT 1_CD enzymes_NNS [_NN 9_CD ]_NN ._. Likewise_RB ,_, the_DT crystal_NN structure_NN
        reported_VBD for_IN mouse_NN ALDH_NNP 1_CD A_DT 2_CD revealed_VBD a_DT substrate_NN channel_NN
        which_WDT could_MD provide_VB specificity_NN for_IN retinal_JJ and_CC exclude_VB
        short-chain_JJ aliphatic_JJ aldehydes_NNS [_NN 10_CD ]_NN ._.
        The_DT specific_JJ role_NN of_IN each_DT enzyme_NN in_IN the_DT regulation_NN of_IN
        retinoid_NN signalling_VBG may_MD depend_VB on_IN the_DT species_NNS ,_, cell_NN type_NN ,_,
        and_CC developmental_NN status_NN of_IN the_DT cell_NN ._. 
        In_IN vitro_NN ,_, purified_JJ mouse_NN [_NN 11_CD ]_NN ,_,
        human_JJ [_NN 12_CD ]_NN ,_, and_CC 
        Xenopus_NNP [_NN 13_CD ]_NN ALDH_NNP 1_CD A_DT 1_CD can_MD
        efficiently_RB oxidize_NN 
        all-trans_JJ retinal_JJ to_TO 
        all-trans_JJ retinoic_JJ acid_NN ._. 
        In_IN vivo_NN ,_, the_DT introduction_NN of_IN ALDH_NNP 1_CD A_DT 1_CD
        mRNA_NN into_IN 
        Xenopus_NNP embryos_NNS induces_VBZ early_JJ
        synthesis_NN of_IN retinoic_JJ acid_NN ,_, while_IN ALDH_NNP 1_CD A_DT 1_CD expression_NN is_VBZ
        detected_VBN during_IN the_DT tail_NN bud_NN stages_NNS of_IN 
        Xenopus_NNP embryogenesis_NNS [_NN 14_CD ]_NN ._.
        ALDH_NNP 1_CD A_DT 2_CD in_IN the_DT mouse_NN [_NN 15_CD ]_NN and_CC rat_NN [_NN 16_CD ]_NN has_VBZ shown_VBN even_RB
        greater_JJR specificity_NN and_CC catalytic_JJ efficiency_NN for_IN retinal_JJ as_IN
        a_DT substrate_NN ._. Immuno-histochemical_NNP analysis_NN of_IN mouse_NN embryos_NNS
        shows_VBZ that_IN ALDH_NNP 1_CD A_DT 1_CD expression_NN occurs_VBZ primarily_RB in_IN cranial_NN
        tissues_NNS ,_, while_IN ALDH_NNP 1_CD A_DT 2_CD expression_NN occurs_VBZ primarily_RB in_IN trunk_NN
        tissue_NN [_NN 17_CD ]_NN ._. In_IN addition_NN ,_, the_DT targeted_VBN knockout_NN of_IN the_DT 
        ALDH_NNP 1_CD A_DT 2_CD gene_NN in_IN mice_NNS results_NNS in_IN a_DT
        significant_JJ decrease_NN in_IN retinoic_JJ acid_NN biosynthesis_NNS and_CC
        early_JJ embryo_NN death_NN [_NN 18_CD ]_NN ._.
        The_DT development_NN of_IN inhibitors_NNS which_WDT can_MD target_VB
        individual_JJ ALDH_NNP enzymes_NNS provides_VBZ one_CD approach_NN for_IN
        addressing_VBG the_DT role_NN of_IN a_DT specific_JJ ALDH_NNP enzyme_NN in_IN the_DT
        oxidation_NN of_IN retinal_JJ to_TO retinoic_JJ acid_NN in_IN a_DT given_VBN cell_NN type_NN ._.
        We_PRP have_VBP identified_VBN 4_CD -_: (_( N_NNP ,_, N-_NNP dipropylamino_NN )_) benzaldehyde_NN
        (_( DPAB_NNP )_) (_( Figure_NN 1_CD B_NNP )_) and_CC 4_CD -_: (_( N_NNP ,_, N-_NNP diethylamino_NN )_) benzaldehyde_NN
        (_( DEAB_NNP )_) as_IN potent_JJ ,_, selective_JJ inhibitors_NNS of_IN ALDH_NNP 1_CD A_DT 1_CD ,_, but_CC not_RB
        ALDH_NNP 2_CD or_CC ALDH_NNP 3_CD ,_, with_IN the_DT dipropyl_NN analog_NN exhibiting_VBG 10_CD -_: fold_VB
        greater_JJR efficacy_NN for_IN inhibition_NN [_NN 19_CD 20_CD ]_NN ._. The_DT effect_NN of_IN
        DPAB_NNP on_IN ALDH_NNP 1_CD A_DT 2_CD has_VBZ not_RB been_VBN reported_VBN ._.
        DEAB_NNP was_VBD first_RB used_VBN to_TO sensitize_VB the_DT mouse_NN leukemic_JJ cell_NN
        line_NN L_NNP 1210_CD /_NN CPA_NNP ,_, which_WDT is_VBZ resistant_JJ to_TO
        4_CD -_: hydroperoxycyclophosphamide_NN (_( 4_CD -_: HC_NNP )_) by_IN virtue_NN of_IN its_PRP$
        overexpression_NN of_IN ALDH_NNP 1_CD A_DT 1_CD ._. Treatment_NNP of_IN L_NNP 1210_CD /_NN CPA_NNP cells_NNS 
        in_IN vitro_NN with_IN 50_CD μM_NN DEAB_NNP abolished_VBD
        the_DT tumor_NN cells_NNS '_POS resistance_NN to_TO 4_CD -_: HC_NNP [_NN 19_CD ]_NN ._. DEAB_NNP also_RB
        exhibited_VBN 
        in_IN vivo_NN efficacy_NN as_IN a_DT ALDH_NNP 1_CD A_DT 1_CD
        inhibitor_NN ,_, as_IN demonstrated_VBN by_IN the_DT toxicity_NN to_TO the_DT
        intestinal_NN crypt_NN cells_NNS in_IN mice_NNS receiving_VBG co-injections_JJ of_IN
        DEAB_NNP and_CC cyclophosphamide_NN [_NN 21_CD ]_NN ._. More_RBR recently_RB ,_, DEAB_NNP has_VBZ
        been_VBN used_VBN to_TO demonstrate_VB that_DT overexpression_NN of_IN human_JJ
        ALDH_NNP 1_CD A_DT 1_CD in_IN transfected_JJ cell_NN lines_NNS is_VBZ sufficient_JJ to_TO cause_VB
        cellular_JJ resistance_NN to_TO the_DT oxazaphosphorines_NNS [_NN 22_CD ]_NN and_CC
        4_CD -_: HC_NNP [_NN 23_CD ]_NN ._. DEAB_NNP has_VBZ also_RB been_VBN an_DT effective_JJ reagent_NN in_IN
        fluorescent-activated_JJ cell_NN sorting_VBG (_( FACS_NNP )_) techniques_NNS to_TO
        isolate_VB human_JJ hematopoietic_JJ stem_NN cells_NNS based_VBN on_IN the_DT
        expression_NN of_IN ALDH_NNP 1_CD A_DT 1_CD activity_NN [_NN 5_CD 6_CD ]_NN ._. In_IN contrast_NN to_TO
        DEAB_NNP and_CC DPAB_NNP ,_, daidzin_NN -_: a_DT natural_JJ product_NN isolated_VBN from_IN 
        Pueraria_NNP lobata_NN (_( the_DT Kudzu_NNP plant_NN )_) -_:
        shows_VBZ specificity_NN for_IN inhibiting_VBG ALDH_NNP 2_CD at_IN concentrations_NNS
        similar_JJ to_TO that_DT of_IN DPAB_NNP used_VBD to_TO inhibit_VB ALDH_NNP 1_CD A_DT 1_CD [_NN 24_CD 25_CD ]_NN ._.
        An_DT inhibitor_NN specific_JJ for_IN ALDH_NNP 1_CD A_DT 2_CD has_VBZ not_RB yet_RB been_VBN
        reported_VBN ._.
        In_IN normal_JJ hematopoiesis_NNS ,_, terminally_RB differentiated_JJ cells_NNS
        are_VBP generated_VBN daily_JJ from_IN a_DT limited_JJ number_NN of_IN pluripotent_NN
        stem_NN cells_NNS ._. The_DT stem_NN cell_NN population_NN must_MD be_VB exquisitely_RB
        regulated_VBN to_TO ensure_VB sufficient_JJ self-renewal_JJ as_IN well_RB as_IN
        commitment_NN to_TO progenitor_NN cells_NNS which_WDT can_MD give_VB rise_NN to_TO
        mature_VB erythrocytes_NNS ,_, platelets_NNS ,_, lymphocytes_NNS ,_, granulocytes_NNS ,_,
        and_CC macrophages_NNS ._. Retinoic_NNP acid_NN appears_VBZ to_TO elicit_NN a_DT complex_JJ
        response_NN of_IN cell_NN proliferation_NN and_CC /_NN or_CC commitment_NN to_TO a_DT more_RBR
        differentiated_JJ cell_NN type_NN ,_, depending_VBG on_IN the_DT differentiation_NN
        state_NN of_IN the_DT cell_NN receiving_VBG the_DT signal_NN [_NN 26_CD 27_CD ]_NN ._.
        The_DT HL-_NNP 60_CD human_JJ promyelocytic_JJ leukemia_NN cell_NN line_NN
        responds_VBZ in_IN culture_NN to_TO sub-micromolar_JJ concentrations_NNS of_IN
        retinoic_JJ acid_NN (_( 
        all-trans_JJ and_CC 
        13_CD -_: cis_NNS )_) by_IN undergoing_VBG terminal_NN
        differentiation_NN to_TO a_DT granulocytic_JJ cell_NN with_IN the_DT ability_NN to_TO
        phagocytose_NN and_CC reduce_VB nitroblue_NN tetrazolium_NN [_NN 28_CD ]_NN ._. The_DT
        response_NN to_TO retinoic_JJ acid_NN in_IN HL-_NNP 60_CD cells_NNS is_VBZ dependent_JJ on_IN
        the_DT expression_NN of_IN the_DT retinoic_JJ acid_NN receptor_NN RAR_NNP α_NN [_NN 29_CD ]_NN ._.
        The_DT use_NN of_IN 
        all-trans_JJ retinoic_JJ acid_NN in_IN
        differentiation_NN therapy_NN for_IN patients_NNS with_IN acute_JJ
        promyelocytic_JJ leukemia_NN has_VBZ resulted_VBN in_IN prolonged_JJ ,_, complete_JJ
        remissions_NNS when_WRB combined_VBN with_IN cytotoxic_JJ chemotherapy_NN ,_, and_CC
        may_MD provide_VB complete_JJ ,_, long-term_JJ remissions_NNS as_IN a_DT single_JJ
        agent_NN [_NN 30_CD ]_NN ._.
        However_RB ,_, the_DT enzyme_NN or_CC enzymes_NNS responsible_JJ for_IN the_DT
        formation_NN of_IN retinoic_JJ acid_NN in_IN the_DT HL_NNP 60_CD cells_NNS have_VBP not_RB been_VBN
        identified_VBN ._. In_IN one_CD report_NN ,_, ALDH_NNP 1_CD A_DT 1_CD protein_NN was_VBD not_RB detected_VBN
        by_IN Western_JJ blot_NN ,_, but_CC enzyme_NN activity_NN was_VBD detected_VBN using_VBG
        flow_NN cytometry_NN and_CC a_DT fluorescent_NN aldehyde_NN substrate_NN [_NN 5_CD ]_NN ._.
        In_IN a_DT second_JJ study_NN ,_, ALDH_NNP 1_CD A_DT 1_CD protein_NN was_VBD detected_VBN using_VBG an_DT
        ELISA_NNP assay_NN and_CC activity_NN was_VBD detected_VBN using_VBG aldophosphamide_NN
        as_IN substrate_NN [_NN 31_CD ]_NN ._. In_IN these_DT two_CD studies_NNS ,_, designed_VBN to_TO
        look_VB at_IN the_DT relationship_NN of_IN ALDH_NNP 1_CD A_DT 1_CD activity_NN to_TO antitumor_NN
        drug_NN resistance_NN ,_, the_DT levels_NNS of_IN ALDH_NNP 1_CD A_DT 1_CD were_VBD low_JJ in_IN HL-_NNP 60_CD
        compared_VBN to_TO other_JJ cell_NN types_NNS ,_, corresponding_JJ to_TO the_DT
        sensitivity_NN of_IN HL-_NNP 60_CD cells_NNS to_TO oxazaphosphorines_NNS ._. ALDH_NNP
        activity_NN has_VBZ been_VBN reported_VBN in_IN HL-_NNP 60_CD cells_NNS using_VBG
        4_CD -_: hydroxynonenal_NN as_IN substrate_NN [_NN 32_CD ]_NN ._. However_RB ,_, since_IN this_DT
        molecule_NN is_VBZ such_JJ a_DT poor_JJ substrate_NN with_IN ALDH_NNP 1_CD compared_VBN to_TO
        ALDH_NNP 3_CD ,_, the_DT measured_VBN activity_NN likely_JJ represents_VBZ only_RB ALDH_NNP 3_CD
        activity_NN ._. ALDH_NNP 3_CD does_VBZ not_RB oxidize_NN 
        all_DT trans_NNS retinal_JJ ._. Expression_NNP of_IN
        ALDH_NNP 1_CD A_DT 2_CD activity_NN in_IN HL-_NNP 60_CD cells_NNS has_VBZ not_RB been_VBN reported_VBN ._.
        Therefore_RB ,_, we_PRP chose_VBD the_DT HL-_NNP 60_CD cell_NN line_NN to_TO assess_VB the_DT role_NN
        of_IN ALDH_NNP 1_CD A_DT 1_CD in_IN the_DT oxidation_NN of_IN retinal_JJ ._.
        The_DT collection_NN of_IN results_NNS demonstrating_VBG that_IN retinal_JJ is_VBZ
        an_DT excellent_JJ substrate_NN for_IN ALDH_NNP 1_CD A_DT 1_CD 
        in_IN vitro_NN ,_, that_IN ALDH_NNP 1_CD A_DT 1_CD is_VBZ
        responsible_JJ for_IN the_DT synthesis_NN of_IN retinoic_JJ acid_NN in_IN the_DT
        cranial_NN tissues_NNS of_IN the_DT mouse_NN embryo_NN ,_, and_CC that_IN hematopoietic_JJ
        stem_NN cells_NNS are_VBP characterized_VBN by_IN high_JJ expression_NN of_IN ALDH_NNP 1_CD A_DT 1_CD ,_,
        have_VBP led_VBN to_TO the_DT hypothesis_NNS that_IN the_DT oxidation_NN of_IN retinal_JJ to_TO
        retinoic_JJ acid_NN is_VBZ a_DT key_JJ physiologic_JJ role_NN for_IN ALDH_NNP 1_CD A_DT 1_CD in_IN
        hematopoietic_JJ stem_NN cells_NNS ._. Our_PRP$ long-term_JJ goal_NN is_VBZ to_TO use_VB DPAB_NNP
        to_TO investigate_VB the_DT role_NN of_IN ALDH_NNP 1_CD A_DT 1_CD in_IN retinoic_JJ acid_NN
        biosynthesis_NNS at_IN different_JJ stages_NNS of_IN hematopoiesis_NNS ._. In_IN this_DT
        paper_NN we_PRP show_VBP that_IN DPAB_NNP is_VBZ a_DT potent_JJ inhibitor_NN of_IN retinal_JJ
        oxidation_NN by_IN murine_NN and_CC human_JJ ALDH_NNP 1_CD A_DT 1_CD ._. However_RB ,_, DPAB_NNP only_RB
        weakly_RB inhibits_NNS the_DT retinal-induced_JJ differentiation_NN of_IN
        HL-_NNP 60_CD cells_NNS ,_, suggesting_VBG that_IN ALDH_NNP 1_CD A_DT 1_CD is_VBZ not_RB the_DT operative_JJ
        retinal_JJ oxidizing_VBG enzyme_NN in_IN these_DT cells_NNS ._.
      
      
        Results_NNS and_CC discussion_NN
        DPAB_NNP is_VBZ a_DT potent_JJ inhibitor_NN of_IN retinal_JJ oxidation_NN with_IN IC_NNP 
        50_CD values_NNS of_IN 0_CD ._. 11_CD and_CC 0_CD ._. 13_CD μM_NN for_IN
        purified_JJ mouse_NN and_CC human_JJ ALDH_NNP 1_CD A_DT 1_CD ,_, respectively_RB (_( Table_NNP 1_LS )_) ._.
        These_DT IC_NNP 
        50_CD values_NNS are_VBP 100_CD -_: fold_VB lower_JJR than_IN the_DT
        retinal_JJ concentrations_NNS used_VBN in_IN the_DT assay_NN ._. The_DT IC_NNP 
        50_CD values_NNS for_IN mouse_NN ALDH_NNP 1_CD A_DT 1_CD are_VBP between_IN
        the_DT values_NNS observed_VBD with_IN propanal_NN (_( 0_CD ._. 040_CD μM_NN )_) and_CC
        phenylacetaldehyde_NN (_( 0_CD ._. 36_CD μM_NN )_) as_IN substrates_NNS ,_, with_IN the_DT human_JJ
        ALDH_NNP 1_CD A_DT 1_CD showing_VBG the_DT same_JJ inhibition_NN with_IN retinal_JJ or_CC
        propanal_NN as_IN substrate_NN ._. The_DT IC_NNP 
        50_CD values_NNS reported_VBD were_VBD initially_RB
        obtained_VBN from_IN spectrophotometric_JJ assays_NNS ,_, and_CC repeated_VBD with_IN
        an_DT HPLC_NNP assay_NN ._. We_PRP were_VBD concerned_VBN with_IN using_VBG a_DT
        spectrophotometric_JJ assay_NN for_IN these_DT inhibition_NN studies_NNS due_JJ
        to_TO the_DT presence_NN of_IN several_JJ absorbing_VBG species_NNS at_IN 340_CD nm_NN ,_,
        including_VBG NADH_NNP ,_, DPAB_NNP ,_, retinal_JJ ,_, and_CC retinoic_JJ acid_NN ._. Thus_RB ,_, we_PRP
        modified_VBN an_DT HPLC_NNP assay_NN in_IN order_NN to_TO directly_RB measure_VB the_DT
        amount_NN of_IN retinoic_JJ acid_NN product_NN formed_VBN ._. Previous_JJ reports_NNS of_IN
        HPLC_NNP assays_NNS for_IN ALDH_NNP reactions_NNS with_IN tissue_NN extracts_NNS used_VBD a_DT
        single_JJ time_NN point_NN at_IN 60_CD min_NN to_TO measure_VB accumulation_NN of_IN
        product_NN ,_, after_IN documenting_VBG that_IN retinoic_JJ acid_NN formation_NN was_VBD
        still_RB linear_JJ in_IN time_NN course_NN experiments_NNS [_NN 33_CD ]_NN ._. In_IN our_PRP$
        hands_NNS ,_, the_DT reaction_NN with_IN purified_JJ enzyme_NN was_VBD only_RB linear_JJ
        for_IN product_NN formation_NN up_IN to_TO 10_CD -_: 15_CD minutes_NNS ._.
        Following_VBG continuous_JJ exposure_NN to_TO 1_CD μM_NN retinoic_JJ acid_NN for_IN
        96_CD hours_NNS ,_, almost_RB 40_CD %_NN of_IN cells_NNS have_VBP differentiated_JJ to_TO
        granulocytes_NNS ,_, as_IN seen_VBN by_IN the_DT positive_JJ NBT_NNP staining_VBG ._.
        Exposure_NNP to_TO 1_CD μM_NN 
        all-trans_JJ retinal_JJ for_IN 96_CD hours_NNS
        induced_VBD differentiation_NN equivalent_JJ to_TO exposure_NN to_TO 0_CD ._. 05_CD -_: 0_CD ._. 1_LS
        μM_NN retinoic_JJ acid_NN ._. With_IN co-exposures_JJ to_TO 1_CD μM_NN retinal_JJ and_CC up_IN
        to_TO 50_CD μM_NN DEAB_NNP or_CC DPAB_NNP ,_, HL-_NNP 60_CD differentiation_NN was_VBD inhibited_VBD
        by_IN only_RB 30_CD %_NN after_IN 144_CD hours_NNS of_IN exposure_NN ,_, compared_VBN with_IN
        cells_NNS exposed_VBN to_TO retinal_JJ alone_RB (_( Figure_NN 2_LS )_) DPAB_NNP did_VBD not_RB
        alter_VB the_DT induction_NN of_IN differentiation_NN by_IN retinoic_JJ acid_NN ,_,
        nor_CC did_VBD it_PRP affect_VBP cell_NN viability_NN up_IN to_TO 144_CD hours_NNS ._. Since_IN
        DPAB_NNP 's_POS inhibition_NN of_IN cell_NN differentiation_NN in_IN cells_NNS exposed_VBN
        to_TO retinal_JJ was_VBD so_RB low_JJ ,_, we_PRP needed_VBD to_TO demonstrate_VB that_DT
        chemical_NN oxidation_NN or_CC any_DT serum_NN enzymatic_JJ oxidation_NN of_IN
        retinal_JJ to_TO retinoic_JJ acid_NN was_VBD not_RB occuring_VBG under_IN our_PRP$ culture_NN
        conditions_NNS ._. Control_NN dishes_NNS containing_VBG media_NNS and_CC retinal_JJ
        were_VBD incubated_JJ for_IN 144_CD hours_NNS ,_, with_IN aliquots_NNS removed_VBD every_DT
        24_CD hours_NNS and_CC analyzed_VBN by_IN HPLC_NNP ._. By_IN day_NN 6_CD ,_, less_JJR than_IN 1_CD %_NN of_IN
        the_DT retinal_JJ was_VBD oxidized_JJ to_TO retinoic_JJ acid_NN ,_, suggesting_VBG that_IN
        non-enzymatic_JJ formation_NN or_CC serum-mediated_JJ formation_NN of_IN
        retinoic_JJ acid_NN was_VBD not_RB responsible_JJ for_IN the_DT observed_VBN
        differentiation_NN in_IN cells_NNS exposed_VBN to_TO DEAB_NNP or_CC DPAB_NNP ._.
        Although_IN DPAB_NNP is_VBZ a_DT more_RBR potent_JJ inhibitor_NN of_IN human_JJ
        ALDH_NNP 1_CD A_DT 1_CD than_IN DEAB_NNP ,_, we_PRP were_VBD concerned_VBN that_IN DPAB_NNP was_VBD not_RB
        remaining_VBG in_IN solution_NN at_IN 50_CD μM_NN in_IN the_DT culture_NN media_NNS ._.
        However_RB ,_, the_DT observation_NN that_IN the_DT addition_NN of_IN DEAB_NNP ,_, a_DT much_RB
        more_RBR soluble_JJ compound_NN ,_, resulted_VBD in_IN the_DT same_JJ percent_NN
        inhibition_NN ,_, suggested_VBD that_DT solubility_NN was_VBD not_RB a_DT factor_NN ._.
        Thus_RB ,_, artifacts_NNS due_JJ to_TO solubility_NN of_IN inhibitor_NN and_CC
        extracellular_NN oxidation_NN of_IN retinal_JJ do_VBP not_RB appear_VB to_TO
        contribute_VB to_TO the_DT observed_VBN response_NN of_IN DPAB_NNP on_IN retinal_JJ
        oxidation_NN ._.
        In_IN addition_NN ,_, the_DT NAD-dependent_NNP oxidation_NN of_IN propanal_NN or_CC
        retinal_JJ was_VBD less_JJR than_IN 0_CD ._. 05_CD nmoles_NNS NADH_NNP formed_VBD /_NN min-_NN 10_CD 7_CD cells_NNS
        in_IN spectrophotometric_JJ assays_NNS using_VBG HL-_NNP 60_CD cell_NN extracts_NNS ,_,
        even_RB in_IN the_DT absence_NN of_IN DEAB_NNP or_CC DPAB_NNP ._. The_DT NAD-dependent_NNP
        oxidation_NN of_IN these_DT aldehydes_NNS was_VBD not_RB reproducibly_RB detected_VBD
        above_IN background_NN in_IN spectrofluorometric_JJ assays_NNS ._. Therefore_RB ,_,
        though_IN low_JJ levels_NNS of_IN ALDH_NNP 1_CD A_DT 1_CD activity_NN have_VBP been_VBN reported_VBN in_IN
        HL-_NNP 60_CD cells_NNS in_IN previous_JJ studies_NNS [_NN 5_CD 31_CD ]_NN ,_, it_PRP appears_VBZ that_IN
        the_DT differentiation_NN observed_VBD in_IN cells_NNS exposed_VBN to_TO retinal_JJ
        alone_RB or_CC retinal_JJ plus_CC DPAB_NNP was_VBD not_RB mediated_JJ by_IN ALDH_NNP 1_CD A_DT 1_CD
        oxidation_NN of_IN retinal_JJ to_TO retinoic_JJ acid_NN ._. One_CD possibility_NN is_VBZ
        that_IN a_DT cytochrome_NN P_NN 450_CD (_( CYP_NNP )_) enzyme_NN is_VBZ catalyzing_VBG the_DT
        oxidation_NN ._. Raner_NNP et_CC al_NN [_NN 34_CD ]_NN and_CC Chen_NNP et_CC al_NN [_NN 35_CD ]_NN have_VBP
        described_VBN the_DT formation_NN of_IN all-trans_JJ retinoic_JJ acid_NN from_IN
        retinal_JJ and_CC retinol_NN by_IN members_NNS of_IN the_DT CYP_NNP 1_CD and_CC CYP_NNP 3_CD A_DT
        families_NNS ._. In_IN addition_NN ,_, expression_NN of_IN CYP_NNP 1_CD A_DT 1_CD and_CC CYP_NNP 3_CD A_DT 4_CD mRNA_NN
        has_VBZ been_VBN reported_VBN in_IN HL-_NNP 60_CD cells_NNS [_NN 36_CD ]_NN ._. The_DT contribution_NN
        of_IN ALDH_NNP 1_CD A_DT 2_CD also_RB ca_MD n't_RB be_VB ruled_VBN out_RP ._. However_RB ,_, its_PRP$ activity_NN
        should_MD be_VB detected_VBN by_IN the_DT spectrophotometric_JJ or_CC
        fluorometric_JJ assays_NNS ._.
        Although_IN ALDH_NNP 1_CD A_DT 2_CD appears_VBZ only_RB to_TO catalyze_NN the_DT oxidation_NN
        of_IN 
        all-trans_JJ retinal_JJ to_TO 
        all-trans_JJ retinoic_JJ acid_NN ,_, both_DT ALDH_NNP 1_CD A_DT 1_CD
        and_CC CYP_NNP 1_CD and_CC CYP_NNP 3_CD A_DT [_NN 34_CD ]_NN enzymes_NNS are_VBP capable_JJ of_IN oxidizing_VBG 
        9_CD -_: cis_NNS retinal_JJ to_TO 
        9_CD -_: cis_NNS retinoic_JJ acid_NN ._. The_DT family_NN of_IN
        retinoic_JJ acid_NN receptors_NNS includes_VBZ those_DT that_DT bind_NN only_RB 
        all-trans_JJ retinoic_JJ acid_NN (_( RAR_NNP α_NN ,_, β_NN ,_, γ_NN
        and_CC those_DT that_DT bind_NN either_DT 
        all-trans_JJ retinoic_JJ acid_NN or_CC 
        9_CD -_: cis_NNS retinoic_JJ acid_NN (_( RXR_NNP α_NN ,_, β_NN ,_, γ_NN Since_IN
        the_DT transcriptional_NN regulation_NN of_IN the_DT retinoic_JJ acid_NN
        ligand_NN /_NN receptor_NN complex_JJ appears_VBZ to_TO involve_VB the_DT binding_JJ of_IN
        receptor_NN heterodimers_NNS (_( RAR_NNP /_NN RXR_NNP )_) ,_, the_DT specific_JJ cellular_JJ
        response_NN may_MD depend_VB on_IN the_DT ratio_NN of_IN 
        all-trans_JJ to_TO 
        9_CD -_: cis_NNS retinoic_JJ acid_NN formed_VBD ,_, as_RB well_RB
        as_IN the_DT expression_NN of_IN receptor_NN subtypes_NNS ._.
        Our_PRP$ results_NNS suggest_VBP an_DT intriguing_JJ possibility_NN that_DT
        regulation_NN of_IN retinoic_JJ acid_NN formation_NN in_IN the_DT HL-_NNP 60_CD cells_NNS ,_,
        and_CC the_DT subsequent_JJ terminal_NN differentiation_NN to_TO
        granulocytes_NNS ,_, could_MD be_VB mediated_JJ by_IN one_CD enzymatic_JJ acitivy_NN ,_,
        e_SYM ._. g_SYM ._. a_DT CYP-mediated_NNP oxidation_NN of_IN retinal_JJ ,_, whereas_IN
        regulation_NN of_IN retinoic_JJ acid_NN formation_NN in_IN the_DT hematopoietic_JJ
        stem_NN cells_NNS ,_, and_CC the_DT subsequent_JJ maintenance_NN of_IN the_DT
        self-renewal_JJ capacity_NN of_IN the_DT hematopoietic_JJ stem_NN cells_NNS ,_, is_VBZ
        mediated_JJ by_IN ALDH_NNP 1_CD A_DT 1_CD oxidation_NN of_IN retinal_JJ (_( Figure_NN 3_LS )_) ._. This_DT
        hypothesis_NNS can_MD be_VB tested_VBN by_IN using_VBG global_JJ or_CC specific_JJ CYP_NNP
        inhibitors_NNS in_IN the_DT presence_NN of_IN retinal_JJ in_IN HL-_NNP 60_CD cells_NNS and_CC by_IN
        using_VBG DPAB_NNP in_IN the_DT presence_NN of_IN retinal_JJ in_IN an_DT hematopoietic_JJ
        stem_NN cell_NN assay_NN system_NN ._. We_PRP are_VBP attempting_VBG to_TO assess_VB the_DT
        ability_NN of_IN DPAB_NNP to_TO block_VB retinoic_JJ acid_NN formation_NN in_IN
        cultured_JJ ,_, mouse_NN hematopoietic_JJ stem_NN cells_NNS ._.
      
      
        Conclusions_NNP
        We_PRP have_VBP shown_VBN that_IN DPAB_NNP can_MD serve_VB as_IN a_DT potent_JJ inhibitor_NN
        of_IN purified_JJ human_NN and_CC mouse_NN ALDH_NNP 1_CD A_DT 1_CD and_CC should_MD be_VB a_DT useful_JJ
        molecule_NN to_TO assess_VB the_DT role_NN of_IN ALDH_NNP 1_CD A_DT 1_CD in_IN retinal_JJ oxidation_NN
        in_IN a_DT cell_NN system_NN ._. In_IN addition_NN ,_, our_PRP$ results_NNS indicate_VBP that_IN in_IN
        HL_NNP 60_CD cells_NNS ,_, the_DT prototype_NN cell_NN line_NN for_IN studying_VBG retinoic_JJ
        acid_NN induced_VBD cell_NN differentiation_NN ,_, ALDH_NNP 1_CD A_DT 1_CD is_VBZ not_RB the_DT
        operative_JJ oxidizing_VBG enzyme_NN for_IN retinal_JJ ._.
      
      
        Materials_NNS and_CC methods_NNS
        
          Materials_NNS
          NAD_NNP ,_, 
          all-trans_JJ retinal_JJ ,_, 
          all-trans_JJ retinoic_JJ acid_NN ,_,
          dimethylsulfoxide_NN ,_, mammalian_JJ protease_NN inhibitor_NN cocktail_NN ,_,
          nitroblue_NN tetrazolium_NN ,_, and_CC pyrazole_NN were_VBD obtained_VBN from_IN
          Sigma_NNP Chemical_NNP Co_NNP ._. ,_, St_NNP ._. Louis_NNP ,_, MO_NNP ._. Phenylacetaldehyde_NNP ,_,
          4_CD -_: (_( N_NNP ,_, N-_NNP diethylamino_NN )_) benzaldehyde_NN ,_, and_CC propanal_NN were_VBD
          purchased_VBN from_IN Aldrich_NNP Chemical_NNP Co_NNP ._. ,_, Milwaukee_NNP ,_, WI_NNP ._.
        
        
          Purification_NNP of_IN ALDH_NNP 1_CD A_DT 1_CD from_IN mouse_NN liver_NN and_CC human_JJ
          erythrocytes_NNS
          The_DT purification_NN of_IN ALDH_NNP 1_CD A_DT 1_CD from_IN mouse_NN liver_NN and_CC human_JJ
          erythrocytes_NNS was_VBD performed_VBN as_IN in_IN [_NN 20_CD ]_NN ._.
        
        
          Substrate_NNP and_CC inhibitor_NN preparations_NNS
          Retinal_NNP and_CC retinoic_JJ acid_NN were_VBD dissolved_VBN in_IN either_DT
          DMSO_NNP or_CC ethanol_NN and_CC stored_VBD as_IN 100_CD mM_NN stock_NN solutions_NNS in_IN
          foil-wrapped_JJ vials_NNS at_IN -_: 20_CD °_NN C_NNP ._. For_IN enzyme_NN assays_NNS ,_, retinal_JJ
          prepared_VBN in_IN DMSO_NNP was_VBD diluted_VBN in_IN a_DT 70_CD %_NN methanol_NN :_: 30_CD %_NN water_NN
          (_( v_NN /_NN v_NN )_) solution_NN and_CC all_DT assays_NNS were_VBD run_VBN under_IN dim_NN light_JJ ._.
          DPAB_NNP was_VBD synthesized_JJ as_IN described_VBN in_IN [_NN 20_CD ]_NN and_CC stored_VBD as_IN
          a_DT yellow_JJ oil_NN at_IN 4_CD °_NN C_NNP ._. DPAB_NNP was_VBD diluted_VBN in_IN DMSO_NNP to_TO a_DT stock_NN
          concentration_NN of_IN 10_CD mM_NN and_CC then_RB diluted_VBN in_IN water_NN prior_RB to_TO
          enzyme_NN assays_NNS ._. DMSO_NNP concentration_NN did_VBD not_RB exceed_VB 0_CD ._. 1_CD %_NN
          (_( v_NN /_NN v_NN )_) in_IN the_DT assay_NN and_CC this_DT concentration_NN had_VBD no_DT effect_NN
          on_IN enzyme_NN activity_NN ._.
        
        
          Spectrophotometric_NNP enzyme_NN assays_NNS
          ALDH_NNP 1_CD A_DT 1_CD activity_NN was_VBD measured_VBN on_IN a_DT Shimadzu_NNP UV_NNP 1201_CD
          Spectrophotometer_NNP at_IN 36_CD ._. 5_LS °_NN (_( ±_NN 0_CD ._. 5_CD °_NN )_) at_IN 340_CD nm_NN ._. Standard_JJ
          assay_NN conditions_NNS were_VBD as_IN follows_VBZ :_: 1_CD mL_NN final_JJ reaction_NN
          volume_NN ;_: assay_NN buffer_NN (_( 0_CD ._. 1_LS M_NNP sodium_NN pyrophosphate_NN pH_NN 8_CD ._. 4_CD ,_,
          1_CD ._. 0_CD mM_NN EDTA_NNP ,_, 5_CD ._. 0_CD mM_NN dithiothreitol_NN )_) ;_: 1_CD ._. 0_CD mM_NN NAD_NNP ;_: 10_CD mM_NN
          pyrazole_NN ._. The_DT order_NN of_IN addition_NN in_IN the_DT assay_NN was_VBD as_IN
          follows_VBZ :_: buffer_NN ;_: pyrazole_NN ;_: NAD_NNP ;_: ALDH_NNP (_( 10_CD mU_NN mouse_NN liver_NN
          ALDH_NNP 1_CD A_DT 1_CD ;_: 5_CD mU_NN human_JJ erythrocyte_NN ALDH_NNP 1_CD A_DT 1_CD ;_: or_CC HL-_NNP 60_CD cell_NN
          extract_NN )_) ;_: inhibitor_NN (_( if_IN any_DT )_) ;_: and_CC lastly_RB ,_, the_DT aldehyde_NN
          substrate_NN ._. One_CD Unit_NNP of_IN activity_NN is_VBZ defined_VBN as_IN 1_CD μmole_NN
          NADH_NNP formed_VBD /_NN minute_NN ._. Background_NNP activity_NN was_VBD determined_VBN
          for_IN 60_CD -_: 90_CD seconds_NNS after_IN the_DT addition_NN of_IN enzyme_NN and_CC the_DT
          reaction_NN rate_NN was_VBD measured_VBN during_IN the_DT 30_CD -_: 60_CD seconds_NNS
          following_VBG addition_NN of_IN retinal_JJ substrate_NN Propanal_NNP
          concentration_NN was_VBD varied_VBN from_IN 500_CD to_TO 10_CD μM_NN (_( 20_CD -_: 0_CD ._. 4_LS times_NNS
          K_NNP 
          m_NN )_) ,_, phenylacetaldehyde_NN concentration_NN
          was_VBD varied_VBN from_IN 40_CD to_TO 5_CD μM_NN (_( 5_CD -_: 0_CD ._. 6_CD times_NNS K_NNP 
          m_NN )_) ,_, and_CC retinal_JJ concentration_NN was_VBD
          varied_VBN from_IN 1_CD -_: 10_CD μM_NN ,_, all_DT with_IN constant_JJ (_( 1_CD mM_NN )_) NAD_NNP
          concentration_NN ._. DPAB_NNP concentrations_NNS were_VBD varied_VBN from_IN 20_CD μM_NN
          to_TO 0_CD ._. 05_CD μM_NN ._. All_DT trials_NNS were_VBD done_VBN in_IN triplicate_NN ._.
        
        
          HPLC_NNP enzyme_NN assays_NNS
          Since_IN there_EX are_VBP three_CD molecules_NNS with_IN strong_JJ
          absorbances_NNS at_IN 340_CD nm_NN (_( retinal_JJ ,_, retinoic_JJ acid_NN ,_, and_CC NADH_NNP )_) ,_,
          we_PRP developed_VBD a_DT high_JJ pressure_NN liquid_JJ chromatography_NN (_( HPLC_NNP )_)
          assay_NN to_TO assess_VB the_DT ability_NN of_IN DPAB_NNP to_TO inhibit_VB retinal_JJ
          oxidation_NN by_IN class_NN 1_CD ALDH_NNP ._. Assay_NNP conditions_NNS were_VBD :_: 0_CD ._. 5_CD mL_NN
          final_JJ reaction_NN volume_NN ;_: assay_NN buffer_NN (_( 0_CD ._. 1_LS M_NNP sodium_NN
          pyrophosphate_NN ,_, pH_NN 8_CD ._. 4_CD ,_, 1_CD ._. 0_CD mM_NN EDTA_NNP ,_, 5_CD ._. 0_CD mM_NN dithiothreitol_NN
          or_CC glutathione_NN )_) ;_: 1_CD ._. 0_CD mM_NN NAD_NNP ._. The_DT reaction_NN rate_NN was_VBD
          measured_VBN at_IN 37_CD °_NN C_NNP for_IN 1_CD -_: 10_CD minutes_NNS ._. The_DT reaction_NN was_VBD
          stopped_VBN by_IN the_DT addition_NN of_IN 200_CD μL_NN butanol_NN ._. After_IN
          vortexing_VBG for_IN 1_CD minute_NN ,_, 50_CD μL_NN of_IN saturated_VBD K_NNP 
          2_CD HPO_NNP 
          4_CD was_VBD added_VBN ._. The_DT sample_NN was_VBD vortexed_JJ
          and_CC centrifuged_JJ for_IN 2_CD minutes_NNS at_IN 16_CD ,_, 000_CD g_SYM ._. 50_CD μL_NN of_IN the_DT
          resulting_VBG organic_JJ layer_NN was_VBD injected_VBN onto_IN a_DT reverse_JJ phase_NN
          C_NNP 18_CD column_NN (_( Phenomenex_NNP )_) ._. The_DT mobile_JJ phase_NN was_VBD 0_CD ._. 5_CD %_NN acetic_JJ
          acid_NN :_: 20_CD %_NN water_NN :_: 79_CD ._. 5_LS %_NN acetonitrile_NN (_( v_NN /_NN v_NN )_) with_IN a_DT flow_NN
          rate_NN of_IN 2_CD ._. 0_CD mL_NN /_NN min_NN ._. 
          All-trans_NNP retinal_JJ and_CC 
          all-trans_JJ retinoic_JJ acid_NN were_VBD
          detected_VBN at_IN 360_CD nm_NN with_IN retention_NN times_NNS of_IN 10_CD ._. 0_CD and_CC 7_CD ._. 7_CD
          minutes_NNS ,_, respectively_RB ._.
        
        
          HPLC_NNP assay_NN for_IN detection_NN of_IN retinal_JJ purity_NN and_CC
          stability_NN in_IN culture_NN
          HPLC_NNP was_VBD used_VBN to_TO analyze_VB the_DT purity_NN of_IN our_PRP$ retinal_JJ
          samples_NNS and_CC the_DT stability_NN of_IN retinal_JJ under_IN culture_NN
          conditions_NNS ._. The_DT stability_NN of_IN retinal_JJ in_IN tissue_NN culture_NN
          was_VBD determined_VBN by_IN incubation_NN of_IN 10_CD μM_NN retinal_JJ in_IN culture_NN
          media_NNS (_( RPMI_NNP 1640_CD plus_CC 15_CD %_NN fetal_JJ bovine_JJ serum_NN )_) for_IN six_CD
          days_NNS at_IN 37_CD °_NN C_NNP ._. At_IN 24_CD hour_NN intervals_NNS ,_, 1_CD mL_NN of_IN media_NNS was_VBD
          removed_VBN ._. 200_CD mL_NN of_IN 50_CD %_NN butanol_NN :_: 50_CD %_NN acetonitrile_NN (_( v_NN /_NN v_NN )_) was_VBD
          added_VBN and_CC the_DT mixture_NN was_VBD vortexed_JJ for_IN 60_CD seconds_NNS ,_,
          followed_VBN by_IN centrifugation_NN for_IN 2_CD minutes_NNS at_IN 16_CD ,_, 000_CD ×_NN g_SYM ._.
          The_DT top_JJ organic_JJ layer_NN was_VBD removed_VBN and_CC diluted_VBN 1_CD :_: 5_CD in_IN
          acetonitrile_NN before_IN injection_NN onto_IN the_DT HPLC_NNP column_NN ._.
        
        
          Cell_NNP differentiation_NN assays_NNS
          HL-_NNP 60_CD cells_NNS (_( ATCC_NNP ,_, Rockville_NNP ,_, MD_NNP )_) were_VBD propagated_JJ in_IN
          RPMI-_NNP 1640_CD media_NNS supplemented_JJ with_IN 15_CD %_NN fetal_JJ bovine_JJ serum_NN
          and_CC 50_CD U_NNP /_NN mL_NN penicillin_NN and_CC 0_CD ._. 5_CD mg_NN /_NN mL_NN streptomycin_NN ._. Cells_NNP
          were_VBD subcultured_JJ and_CC treated_VBN at_IN 2_CD ×_NN 10_CD 5_CD cells_NNS /_NN mL_NN ._. Cells_NNP
          were_VBD exposed_VBN to_TO combinations_NNS of_IN 1_CD μM_NN retinoic_JJ acid_NN ,_, 1_CD μM_NN
          retinal_JJ ,_, and_CC various_JJ concentrations_NNS of_IN DPAB_NNP and_CC DEAB_NNP
          prepared_VBD in_IN sterile_JJ dimethyl_NN sulfoxide_NN (_( DMSO_NNP )_) or_CC ethanol_NN ._.
          Final_JJ concentrations_NNS of_IN DMSO_NNP or_CC ethanol_NN in_IN the_DT culture_NN
          medium_NN did_VBD not_RB exceed_VB 1_CD %_NN v_NN /_NN v_NN ._. Cells_NNP were_VBD exposed_VBN for_IN up_IN
          to_TO 144_CD hours_NNS without_IN replacement_NN of_IN media_NNS or_CC washing_VBG out_IN
          of_IN retinoid_NN or_CC inhibitor_NN ._. Cell_NNP differentiation_NN was_VBD
          measured_VBN by_IN mixing_VBG 100_CD μL_NN aliquots_NNS of_IN cells_NNS with_IN 100_CD μL_NN
          of_IN a_DT solution_NN containing_VBG 1_CD ._. 0_CD %_NN w_NN /_NN v_NN bovine_JJ serum_NN albumin_NN ,_,
          0_CD ._. 2_CD %_NN w_NN /_NN v_NN nitroblue_NN tetrazolium_NN and_CC 1_CD ._. 0_CD μg_NN /_NN mL_NN of_IN
          12_CD -_: O-_NNP tetradecanoylphorbol_NN 13_CD -_: acetate_NN (_( TPA_NNP )_) ._. The_DT mixture_NN
          was_VBD incubated_JJ for_IN 45_CD minutes_NNS at_IN 37_CD °_NN C_NNP in_IN a_DT 24_CD -_: well_RB plate_NN ._.
          Cells_NNP were_VBD pipetted_JJ onto_IN a_DT Bright_NNP Line_NNP counting_VBG chamber_NN
          and_CC scored_VBD as_IN positive_JJ for_IN differentiation_NN by_IN the_DT
          presence_NN of_IN purple_JJ NBT_NNP precipitate_NN using_VBG bright_JJ field_NN
          microscopy_NN ._. Two_CD observers_NNS each_DT counted_VBN two_CD fields_NNS of_IN at_IN
          least_JJS 200_CD cells_NNS from_IN each_DT well_RB of_IN treated_VBN cells_NNS ._. Cell_NNP
          survival_NN was_VBD determined_VBN by_IN Trypan_NNP blue_JJ dye_NN exclusion_NN ._.
        
        
          Spectrofluorometric_NNP assays_NNS for_IN ALDH_NNP activity_NN in_IN
          HL-_NNP 60_CD Cells_NNP
          Cytosolic_NNP extracts_NNS of_IN HL-_NNP 60_CD cells_NNS were_VBD analyzed_VBN for_IN
          ALDH_NNP activity_NN using_VBG a_DT Perkin_NNP Elmer_NNP 650_CD spectrofluorometer_NN
          with_IN an_DT excitation_NN wavelength_NN of_IN 350_CD nM_NN and_CC an_DT emission_NN
          wavelength_NN of_IN 460_CD nM_NN ._. Assay_NNP conditions_NNS were_VBD as_IN given_VBN for_IN
          the_DT spectrophotometric_JJ enzyme_NN assays_NNS above_IN ,_, with_IN propanal_NN
          or_CC 
          all-trans_JJ retinal_JJ used_VBN as_IN the_DT
          aldehyde_NN substrate_NN ._.
        
      
    
  
